TENET HEALTHCARE CORP (THC) Forecast, Price Target & Analyst Ratings

NYSE:THC • US88033G4073

Current stock price

192 USD
-1.56 (-0.81%)
At close:
192.25 USD
+0.25 (+0.13%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for TENET HEALTHCARE CORP (THC).

Forecast Snapshot

Consensus Price Target

Price Target
$262.79
+ 36.87% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Apr 30, 2026
Period
Q1 / 2026
EPS Estimate
$4.21
Revenue Estimate
5.451B
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
81.43%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$262.79
Upside
+ 36.87%
From current price of $192.00 to mean target of $262.79, Based on 28 analyst forecasts
Low
$175.18
Median
$270.30
High
$302.40

Price Target Revisions

1 Month
2.92%
3 Months
9.99%

Price Target Summary

28 Wall Street analysts provided a forecast for the next 12 months for THC. The average price target is 262.79 USD. This implies a price increase of 36.87% is expected in the next year compared to the current price of 192.
The average price target has been revised upward by 9.99% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

THC Current Analyst RatingTHC Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 5 10 15

Analyst Ratings History

THC Historical Analyst RatingsTHC Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15 20 25

Analyst Ratings Consensus

ChartMill Buy Consensus
81.43%
THC was analyzed by 28 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about THC.
In the previous month the buy percentage consensus was at a similar level.
THC was analyzed by 28 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-12MizuhoMaintains Outperform -> Outperform
2026-03-12GuggenheimMaintains Buy -> Buy
2026-02-20Leerink PartnersMaintains Outperform -> Outperform
2026-02-17Truist SecuritiesMaintains Buy -> Buy
2026-02-13GuggenheimMaintains Buy -> Buy
2026-02-13BarclaysMaintains Overweight -> Overweight
2026-02-12UBSMaintains Buy -> Buy
2026-02-12KeybancMaintains Overweight -> Overweight
2026-02-12RBC CapitalMaintains Outperform -> Outperform
2026-02-12JefferiesMaintains Buy -> Buy
2026-02-03RBC CapitalMaintains Outperform -> Outperform
2026-01-07TD CowenMaintains Buy -> Buy
2026-01-07Wells FargoMaintains Overweight -> Overweight
2025-12-02GuggenheimMaintains Buy -> Buy
2025-11-21BarclaysMaintains Overweight -> Overweight
2025-11-13Wells FargoMaintains Overweight -> Overweight
2025-11-13JP MorganMaintains Overweight -> Overweight
2025-11-03Truist SecuritiesReiterate Buy -> Buy
2025-10-30RBC CapitalMaintains Outperform -> Outperform
2025-10-29Cantor FitzgeraldMaintains Overweight -> Overweight
2025-10-29GuggenheimMaintains Buy -> Buy
2025-10-29UBSMaintains Buy -> Buy
2025-10-17MizuhoMaintains Outperform -> Outperform
2025-10-08KeybancMaintains Overweight -> Overweight
2025-10-07Cantor FitzgeraldReiterate Overweight -> Overweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
Apr 30, 2026
Period
Q1 / 2026
EPS Estimate
$4.21
Revenue Estimate
5.451B
Revenue Q2Q
4.37%
EPS Q2Q
-3.55%
Number of Analysts
21

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
-0.98%
EPS (1 Month)
0.00%
EPS (3 Months)
-5.94%

Next Earnings Summary

THC is expected to report earnings on 4/30/2026. The consensus EPS estimate for the next earnings is 4.21 USD and the consensus revenue estimate is 5.45B USD.
The next earnings revenue estimate has been revised downward by 0.98% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
THC revenue by date.THC revenue by date.
20.564B
7.25%		20.675B
0.54%		21.31B
3.07%		22.24B
4.36%		22.659B
1.88%		23.944B
5.67%		24.52B
2.41%		26.301B
7.26%		26.479B
0.68%		27.583B
4.17%		28.701B
4.05%
EBITDA
YoY % growth
THC ebitda by date.THC ebitda by date.
3.682B
17.71%		4.044B
9.83%		4.643B
14.81%		4.664B
0.45%		4.763B
2.12%		5.075B
6.55%		5.252B
3.49%		5.486B
4.46%		5.35B
-2.48%		5.571B
4.13%		5.795B
4.02%
EBIT
YoY % growth
THC ebit by date.THC ebit by date.
2.812B
22.96%		3.226B
14.72%		3.78B
17.17%		3.731B
-1.30%		3.776B
1.21%		3.908B
3.50%		4.095B
4.79%		4.312B
5.30%		4.363B
1.18%		4.559B
4.49%		4.757B
4.34%
Operating Margin
THC operating margin by date.THC operating margin by date.
13.67%15.60%17.74%16.78%16.66%16.32%16.70%16.39%16.48%16.53%16.57%
EPS
YoY % growth
THC eps by date.THC eps by date.
6.98
2.20%		11.90
70.49%		16.78
41.01%		17.17
2.32%		17.86
4.04%		20.65
15.61%		21.81
5.61%		20.04
-8.13%		20.43
1.97%		23.49
14.98%		26.11
11.13%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28 Q4 / 28
EPS
Q2Q % growth		4.21
-3.55%		4.29
6.81%		4.14
11.77%		4.72
0.32%		4.40
4.52%		4.38
2.11%		4.28
3.53%		5.04
6.83%		5.13
16.74%		4.62
5.28%		4.30
0.50%		5.27
4.67%
Revenue
Q2Q % growth		5.451B
4.37%		5.494B
4.23%		5.515B
4.27%		5.768B
4.36%		5.508B
1.05%		5.53B
0.66%		5.551B
0.65%		5.833B
1.13%		5.858B
6.35%		5.858B
5.93%		5.858B
5.53%		6.161B
5.62%
EBITDA
Q2Q % growth		1.13B
-5.36%		1.157B
-13.72%		1.147B
-25.03%		1.261B
-31.09%		1.149B
1.68%		1.166B
0.78%		1.155B
0.70%		1.288B
2.14%		N/AN/AN/AN/A
EBIT
Q2Q % growth		890.99M
-9.82%		923.11M
-0.42%		906.51M
0.95%		1.005B
3.93%		841.53M
-5.55%		848.93M
-8.04%		834.36M
-7.96%		948.47M
-5.62%		N/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

THC Yearly Revenue VS EstimatesTHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B 20B 25B
THC Yearly EPS VS EstimatesTHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15 20 25

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
7.17%
EPS Next 5 Year
3.61%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
3.67%
Revenue Next 5 Year
4.13%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
10.68%
EBIT Next 5 Year
7.95%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

TENET HEALTHCARE CORP / THC Forecast FAQ

What is the average price target for TENET HEALTHCARE CORP (THC) stock?

28 analysts have analysed THC and the average price target is 262.79 USD. This implies a price increase of 36.87% is expected in the next year compared to the current price of 192.

Can you provide the upcoming earnings date for TENET HEALTHCARE CORP?

TENET HEALTHCARE CORP (THC) will report earnings on 2026-04-30, after the market close.

What are the consensus estimates for THC stock next earnings?

The consensus EPS estimate for the next earnings of TENET HEALTHCARE CORP (THC) is 4.21 USD and the consensus revenue estimate is 5.45B USD.

How do analysts rate TENET HEALTHCARE CORP (THC)?

The consensus rating for TENET HEALTHCARE CORP (THC) is 81.4286 / 100 . This indicates that analysts generally have a positive outlook on the stock.